The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity

Navid Reza Mashayekhi1, Saeid Sadrnia1, Ali Chehrei2

  • 1Amirkabir Hospital, Arak University of Medical Sciences, Arak, IR Iran.

Insights

Apolipoprotein B (ApoB) correlates with coronary artery disease (CAD) severity and predicts ischemic heart disease (IHD) better than traditional risk factors. ApoB offers a valuable addition to CAD risk assessment.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Coronary Artery Disease (CAD) affects individuals without typical risk factors.
  • Cardiovascular events can occur unexpectedly in some patients.
  • Identifying novel predictors for CAD and Ischemic Heart Disease (IHD) is crucial.

Purpose of the Study:

  • To evaluate the association between Apolipoprotein A1 (ApoA1) and Apolipoprotein B (ApoB) levels and CAD severity.
  • To determine if ApoA1 and ApoB are superior predictors of IHD compared to existing methods.

Main Methods:

  • A case-control study involving 271 individuals undergoing coronary angiography.
  • CAD severity was quantified using the Gensini score.
  • Logistic regression and Receiver Operating Characteristic (ROC) analysis were employed.

Main Results:

  • No significant correlation was found between ApoA1 and CAD severity (P = 0.797).
  • A significant positive correlation was observed between ApoB and CAD severity (P = 0.047).
  • ApoB, sex, diabetes mellitus (DM), and family history (FH) were identified as significant predictors of IHD (P < 0.048).
  • ROC analysis indicated ApoB is a more effective predictor of CAD than angiography (P = 0.023).

Conclusions:

  • ApoB measurement is a valuable addition to conventional risk assessment for CAD.
  • ApoB may serve as a more effective biomarker for predicting IHD.
  • Further research is recommended to elucidate the role of ApoB in CAD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620